Kenya's New Regulations Require Health Warning Images on Tobacco Products

Regulations by 2FIRSTS.ai

May.07.2024

Kenya's New Regulations Require Health Warning Images on Tobacco Products

Kenya Health Department mandates prominent health warning images covering at least 80% of tobacco product packaging starting May 2.

According to a recent report by Standard Media, the Kenyan Ministry of Health has started accepting public feedback on controversial new tobacco product health warning images starting from May 2nd.

New regulations require tobacco manufacturers to cover at least 80% of the packaging of nicotine products such as cigarettes, nicotine pouches, and e-cigarettes with striking health warning images to raise public awareness of the dangers of smoking.

The Ministry of Health stated in a public announcement that the purpose of these graphic warnings is to increase public awareness of the risks of tobacco use, prevent new smokers, reduce tobacco consumption, and encourage smokers to quit. Furthermore, the necessity of graphic warnings is emphasized to address language barriers and difficulties in understanding textual information.

References:

[1] Public hearings on controversial tobacco packaging rules kick off

Also Read:

[1] BAT Kenya Calls for Differentiated Taxation on Emerging Tobacco Products

[2] BAT Kenya Faces Delay in New Nicotine Pouch Product Launch

[3] Kenya Crackdown on Illegal Nicotine and Unauthorized Drugs

[4] Kenyan Government Relaxes Health Warnings on BAT Products

[5] BAT's Pressure Weakens Health Warnings on Velo Nicotine Pouches

#Traditional tobacco #Africa #Kenya #Regulation #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.

Nov.26

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Philip Morris Korea Extends IQOS ILUMA i Warranty to 18 Months, Says Move Will Boost Smoke-Free Product Growth

Philip Morris International’s Korea unit has extended the warranty for the “IQOS ILUMA i” heated tobacco series from 12 to 18 months, applying it retroactively to existing purchases, aiming to enhance user experience and market competitiveness.

Oct.15 by 2FIRSTS.ai

Russian Duma Committee Moves to Embed Local Vape Prohibitions

Fedot Tumusov, First Deputy Chair of the Duma Health Committee, called vapes the “most dangerous and least controlled” nicotine product and said restricting them should be a priority. While refining a government bill, the committee proposes granting regions the power to ban vape sales. Committee Chair Sergey Leonov said the illicit e-cig market exceeds 60%, with new licensing aimed at cleaning up the sector.